Pancreaticolbiliary Cytology - Problem Cases
Judy Pang, MD
EUS-FNAs of pancreatic masses and bile duct brushings are effective modalities in the diagnostic workup of patients with suspected neoplasms. Nonetheless, diagnostically challenging cases are occasionally encountered. How do we as pathologists communicate our level of concern for neoplasm in our reports when we cannot render a definitive cytologic diagnosis and how will this affect the patient’s clinical management? What adjunct testing modalities are available to reconcile indeterminate cytologic interpretations? This course will emphasize what pathologists need to include in a report if an indeterminate diagnosis (atypical/suspicious) is rendered and what the possible clinical implications of that report could be.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Participants will understand the clinical implications of pre-operative cytology in the evaluation of solid and cystic pancreatic masses and ancillary tests that may be helpful
- Participants will understand the limitations of cytology in the evaluation of bile duct brushings in patients with stents and primary sclerosing cholangitis and ancillary tests that may be helpful.
- Participants will understand what information should be included in a report with an indeterminate diagnosis and the possible clinical implications.
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Judy Pang, MD
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant